Answers are grounded in this paper and cite their sources.
Assessing treatment effectiveness for acute tonsillopharyngitis in children, highlighting Coldysept's benefits over standard therapy.
Acute tonsillopharyngitis is one of the main reasons for prescribing antibiotics to children. Inappropriate use of antibiotics in children often leads to the development of antibioticresistance. Aim - to investigate the effectiveness and safety of the use "Coldysept nanoSilver throat spray" compared to standard therapy to optimize the treatment of acute tonsillopharyngitis in children. Materials and methods. 80 patients aged 6 to 17 years with signs of acute respiratory infection of the upper respiratory tract were observed and divided into two groups. The main group consisted of 50 patients who received standard therapy with "Coldysept nanoSilver throat spray" for 7 days, the comparison group consisted of 30 patients who received standard therapy according to guidelines. Results. The effectiveness of the "Coldysept nanoSilver throat spray" use in the therapy of children on the 3rd day was associated with a significantly better reduction of sore throat, difficulty swallowing and plaque on the tonsils. The frequency registration of the minimum score of acute process symptoms severity on the 5th day treatment demonstrates a similar prevalence of them in main group. On the 7th day of therapy, these symptoms were not observed in patients in the main group, while in children in the control group the symptoms persisted. Conclusions. The obtained data of the dynamic comparative analysis of the use of “Coldisept nanoSilver throat spray” in the complex treatment of children with acute upper respiratory tract infections compared to standard tactics confirm that the proposed approach significantly accelerates recovery with good tolerability and safety of use. The research was carried out in accordance with the principles of the Declaration of Helsinki. Informed consent of the child and child's parents was obtained for the researches. No conflict of interest was declared by the author.
No takes yet. Share an insight, caveat, or question.
Колоскова et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: